Literature DB >> 19183144

Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies.

R Sweis1, M Fox, R Anggiansah, A Anggiansah, K Basavaraju, R Canavan, T Wong.   

Abstract

BACKGROUND: Standard pH monitoring is performed over 24 h with a naso-oesophageal catheter (C-pH). Limitations include naso-pharyngeal discomfort, nausea and social embarrassment resulting in reduced reflux-provoking activities. Recently a catheter-free pH-monitoring technique has become available. The tolerability and diagnostic yield of this system in patients who failed standard monitoring remain unknown. AIM: To examine the tolerability and diagnostic outcome of catheter-free pH-monitoring technique in patients who failed standard monitoring.
METHODS: Patients referred for C-pH and catheter-free pH monitoring completed a tolerability questionnaire. Acid exposure in the distal oesophagus and symptom index (SI) were reviewed.
RESULTS: Over 4 years, 883/1751 (50%) of patients with typical reflux symptoms referred for C-pH were diagnosed with gastro-oesophageal reflux disease (GERD) based on a pathological percentage time acid exposure (%time pH <4);134 (8%) patients failed C-pH and, of these, 129 successfully completed 2-day catheter-free pH monitoring. Ninety-eight (76%) of these patients had a pathological percentage pH <4 on either day compared with 49/102 (49%) of contemporaneous C-pH patients (P < 0.01). There was no difference in SI for heartburn (35% vs. 42%; P = 0.49). The questionnaire demonstrated a preference for catheter-free pH monitoring (96%) with less restriction in activities of daily living, naso-pharyngeal discomfort, dysphagia and chest pain.
CONCLUSIONS: Tolerance and satisfaction with catheter-free pH monitoring are high in patients who had previously failed C-pH; catheter-free pH monitoring assists the definitive diagnosis of GERD in this group.

Entities:  

Mesh:

Year:  2008        PMID: 19183144     DOI: 10.1111/j.1365-2036.2008.03923.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

Review 1.  Endoscopy in the diagnosis and management of motility disorders.

Authors:  Yael Kopelman; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

Review 2.  The role of oesophageal physiological testing in the assessment of noncardiac chest pain.

Authors:  Henriette Heinrich; Rami Sweis
Journal:  Ther Adv Chronic Dis       Date:  2018-09-11       Impact factor: 5.091

3.  Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy.

Authors:  Stephen Hasak; Rena Yadlapati; Osama Altayar; Rami Sweis; Emily Tucker; Kevin Knowles; Mark Fox; John Pandolfino; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2020-01-31       Impact factor: 11.382

4.  Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease.

Authors:  Roberto Penagini; Rami Sweis; Aurelio Mauro; Gerson Domingues; Andres Vales; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

5.  [Modern diagnostic tools for esophageal pathologies].

Authors:  A Kandulski; P Malfertheiner; J Weigt
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

6.  The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.

Authors:  Eun-Young Park; Myung-Gyu Choi; Meonggi Baeg; Chul-Hyun Lim; Jinsu Kim; Yukyung Cho; Jaemyung Park; Inseok Lee; Sangwoo Kim; Kyuyong Choi
Journal:  Dig Dis Sci       Date:  2013-06-14       Impact factor: 3.199

7.  BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.

Authors:  Cheguevara Afaneh; Veronica Zoghbi; Brendan M Finnerty; Anna Aronova; David Kleiman; Thomas Ciecierega; Carl Crawford; Thomas J Fahey; Rasa Zarnegar
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

8.  Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.

Authors:  Reginald C W Bell; Katherine D Freeman
Journal:  Surg Endosc       Date:  2010-12-08       Impact factor: 4.584

9.  GERD assessment including pH metry predicts a high response rate to PPI standard therapy.

Authors:  Arne Kandulski; Ulrich Peitz; Klaus Mönkemüller; Helmut Neumann; Jochen Weigt; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2013-01-16       Impact factor: 3.067

10.  Prolonged 2-day esophageal pH-metry with impedance monitoring improves symptom-reflux association analysis.

Authors:  Agnieszka Swidnicka-Siergiejko; Andrzej Dabrowski
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.